NRG Energy, Inc. Reports Second Quarter Results and Reaffirms 2025 Financial Guidance
Strong financial and operating results; reaffirming 2025 guidance ranges and capital allocation Signed 295 MW of premium, long-term retail agreements for data centers... Read more.
FiscalNote Refinances Senior Secured Term Loan with New Four Year Facility Maturing in 2029 to Drive Long-Term Operating Flexibility
FY25 Guidance Reaffirmed, Reflecting Confidence in Accelerating Momentum from Product-Led Growth Strategy and Ongoing Operational Discipline WASHINGTON–(BUSINESS... Read more.
Aldeyra Therapeutics to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative... Read more.
Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Seasoned Commercial Hematology and Oncology Leader Harout Semerjian Appointed as President and CEO Achieved $49.0 million in RYTELO® net product revenue in Q2 2025... Read more.
Precision BioSciences Announces Phase 1 Safety and Efficacy for Cohort 1, Lowest Dose Level in ELIMINATE-B, a First-In-Human Trial of PBGENE-HBV for Chronic Hepatitis B
– Proof-of-activity now established for PBGENE-HBV, the first and only clinical modality designed to eliminate covalently closed circular DNA (cccDNA) and... Read more.
MarketAxess Announces Trading Volume Statistics for July 2025
12% Growth in Total Credit ADV Driven by 21% Growth in Combined Emerging Markets and Eurobonds ADV NEW YORK–(BUSINESS WIRE)–MarketAxess Holdings Inc.... Read more.
ESPN and the NFL Reach New Agreements To Extend NFL Draft Rights and Add NFL Content and Features to ESPN’s Upcoming Direct-to-Consumer Service
ESPN to Present the NFL Draft with Coverage on ESPN and ABC; ESPN’s Upcoming Direct-to-Consumer Service, Disney+, and Hulu to Stream ESPN and ABC’s Draft Presentations... Read more.
Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2025 Financial Results
– Robust execution with multiple upcoming near-term milestones, including planned Biologics License Application (BLA) submission for veligrotug on track in... Read more.
Cencora Reports Fiscal 2025 Third Quarter Results
Revenue of $80.7 billion for the Third Quarter, an 8.7 percent Increase Year-Over-Year Third Quarter GAAP Diluted EPS of $3.52 and Adjusted Diluted EPS of $4.00... Read more.
DRC Acquires Immersion Legal LLC – Now One of the Largest Trial Consulting Teams in the U.S.
NEW YORK–(BUSINESS WIRE)–Dubin Research & Consulting (“DRC”) and Trivest Partners (“Trivest”) are pleased to announce the acquisition of... Read more.